TP53 Null Mutations Identify Lung Cancer Cell Lines with Highest Sensitivity to the Nontaxane Microtubule Inhibitor EribulinTrista K. Hinz, Lynn E. Heasley|Molecular Pharmacology|2021Cited by 15
Functional RNAi Screens Define Distinct Protein Kinase Vulnerabilities in EGFR-Dependent HNSCC Cell LinesTrista K. Hinz, Lynn E. Heasley|Molecular Pharmacology|2019Cited by 7
Modeling acquired TKI resistance and effective combination therapeutic strategies in murine RET+ lung adenocarcinomaTrista K. Hinz, Lynn E. Heasley|bioRxiv (Cold Spring Harbor Laboratory)|2025Cited by 1